NIVF vs SRXH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

NIVF

59.7
AI Score
VS
NIVF Wins

SRXH

35.7
AI Score

Investment Advisor Scores

NIVF

60score
Recommendation
HOLD

SRXH

36score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric NIVF SRXH Winner
Forward P/E 0.0396 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 11.9% -9.4% NIVF
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 59.7/100 35.7/100 NIVF
Profit Margin 209.0% 0.0% NIVF
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL NIVF

Relative Price Performance (Last 90 Days)

NIVF 1M: -52.3% · 3M: -48.1% SRXH 1M: +3.3% · 3M: +1455.2%

Current Technical Phase

NIVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.7%), weak momentum, RSI 38

RSI (14): 38.1 · Price: $0.58

SRXH

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (84.5% over 20 days), RSI 58

RSI (14): 58.1 · Price: $1.86

Fundamentals Snapshot

Metric NIVF SRXH
Market Cap
Forward P/E 0.0 0.0
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth 0.1% -0.1%
Gross Margin 0.2% 0.3%
Operating Margin -3.5% 0.0%
EPS 108.08 -138.26
Dividend Yield 0.00%

Frequently Asked Questions

Based on our detailed analysis, NIVF is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.